PE20191685A1 - Procesos para la preparacion de un agente inductor de la apoptosis - Google Patents
Procesos para la preparacion de un agente inductor de la apoptosisInfo
- Publication number
- PE20191685A1 PE20191685A1 PE2019001821A PE2019001821A PE20191685A1 PE 20191685 A1 PE20191685 A1 PE 20191685A1 PE 2019001821 A PE2019001821 A PE 2019001821A PE 2019001821 A PE2019001821 A PE 2019001821A PE 20191685 A1 PE20191685 A1 PE 20191685A1
- Authority
- PE
- Peru
- Prior art keywords
- formula
- compound
- tert
- combining
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/455—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation with carboxylic acids or their derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/38—Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings
- C07C47/457—Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
- C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Health & Medical Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Compounds Of Unknown Constitution (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Referido a un proceso para la preparacion de compuestos de formula (C), (D) y (3), donde para obtener el compuesto (C), dicho proceso comprende: (a) combinar un compuesto de formula (A) con R1MgX en un disolvente organico aprotico; en la que R1 es C1 a C6 alquilo y X es CI, Br o I; (b) combinar un C1 a C12 cloroformiato de alquilo o un dicarbonato di-(C1 a C12 alquilo) con el producto de la etapa (a). Para obtener la Formula (D), comprende: (x) combinar un compuesto de formula (B) con un compuesto de formula (C), en donde R es terc-butilo, y una sal de tert-butoxido en un disolvente organico. Para obtener la Formula (3), comprende: (y) combinar un compuesto de formula (B) con un compuesto de formula (C), en donde R es terc-butilo, y una sal de terc-butoxido en un disolvente organico; (z) combinar el compuesto de formula (D), en donde R es terc-butilo; con un compuesto de fuente de paladio, una sal de terc-butoxido y un ligando de fosfina en un disolvente organico aprotico. Dichos compuestos tienen actividad antitumoral como agentes inductores de la apoptosis, siendo utiles para el tratamiento de enfermedades neoplasicas, inmunes o autoinmunes
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361780621P | 2013-03-13 | 2013-03-13 | |
| US201461947850P | 2014-03-04 | 2014-03-04 | |
| PCT/US2014/024224 WO2014165044A1 (en) | 2013-03-13 | 2014-03-12 | Processes for the preparation of an apoptosis-inducing agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20191685A1 true PE20191685A1 (es) | 2019-11-19 |
Family
ID=50439506
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2019001821A PE20191685A1 (es) | 2013-03-13 | 2014-03-12 | Procesos para la preparacion de un agente inductor de la apoptosis |
| PE2015001892A PE20151809A1 (es) | 2013-03-13 | 2014-03-12 | Procesos para la preparacion de un agente inductor de la apoptosis |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2015001892A PE20151809A1 (es) | 2013-03-13 | 2014-03-12 | Procesos para la preparacion de un agente inductor de la apoptosis |
Country Status (31)
| Country | Link |
|---|---|
| EP (5) | EP4019491A1 (es) |
| JP (2) | JP6357220B2 (es) |
| KR (1) | KR102230339B1 (es) |
| CN (3) | CN111960944A (es) |
| AU (2) | AU2014248742B2 (es) |
| BR (3) | BR112015021540B1 (es) |
| CA (3) | CA2903797C (es) |
| CL (1) | CL2015002548A1 (es) |
| CR (1) | CR20150495A (es) |
| CY (1) | CY1120576T1 (es) |
| DK (1) | DK2970263T3 (es) |
| ES (1) | ES2683378T3 (es) |
| HK (2) | HK1216644A1 (es) |
| HR (1) | HRP20181273T1 (es) |
| HU (1) | HUE039046T2 (es) |
| IL (2) | IL240779B (es) |
| LT (1) | LT2970263T (es) |
| MX (2) | MX381065B (es) |
| MY (1) | MY192466A (es) |
| PE (2) | PE20191685A1 (es) |
| PH (2) | PH12015501960B1 (es) |
| PL (1) | PL2970263T3 (es) |
| PT (1) | PT2970263T (es) |
| RS (1) | RS57569B1 (es) |
| RU (1) | RU2660424C2 (es) |
| SG (2) | SG10201701680YA (es) |
| SI (1) | SI2970263T1 (es) |
| TW (2) | TWI735759B (es) |
| UA (1) | UA118667C2 (es) |
| UY (3) | UY39847A (es) |
| WO (1) | WO2014165044A1 (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104370905B (zh) * | 2014-10-22 | 2016-06-01 | 南京友杰医药科技有限公司 | Bcl-2抑制剂ABT-199的合成 |
| US11001582B2 (en) | 2016-03-10 | 2021-05-11 | Assia Chemical Industries Ltd. | Solid state forms of Venetoclax and processes for preparation of Venetoclax |
| CN107089981A (zh) * | 2017-04-24 | 2017-08-25 | 杭州科耀医药科技有限公司 | 一种BCL‑2抑制剂Venetoclax的合成方法 |
| EP4227311A1 (en) | 2017-08-23 | 2023-08-16 | Guangzhou Lupeng Pharmaceutical Company Ltd. | Condensed heterocyclic derivatives as bcl-2 inhibitors for the treatment of neoplastic diseases |
| CN108037196B (zh) * | 2017-11-23 | 2020-06-23 | 中山奕安泰医药科技有限公司 | 一种3-硝基-4-[[(四氢-2h-吡喃-4-基)甲基]氨基]苯磺酰胺的检测方法 |
| AU2019207608B2 (en) | 2018-01-10 | 2024-03-28 | Recurium Ip Holdings, Llc | Benzamide compounds |
| WO2020003272A1 (en) | 2018-06-29 | 2020-01-02 | Fresenius Kabi Oncology Ltd. | An improved process for the preparation of venetoclax |
| CN108997333A (zh) * | 2018-07-04 | 2018-12-14 | 江苏中邦制药有限公司 | 一种b细胞淋巴瘤因子-2抑制剂abt-199的制备方法 |
| WO2020023435A1 (en) | 2018-07-24 | 2020-01-30 | Albany Molecular Research, Inc. | Venetoclax basic salts and processes for the purification of venetoclax |
| WO2020041405A1 (en) | 2018-08-22 | 2020-02-27 | Newave Pharmaceutical Inc. | Bcl-2 inhibitors |
| WO2020049599A1 (en) * | 2018-09-07 | 2020-03-12 | Msn Laboratories Private Limited, R&D Center | Process for the preparation of 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1- yl]methyl}piperazin-1-yl)-n-({3-nitro-4-[(tetrahydro-2h-pyran-4-ylmethyl)amino] phenyl}sulfonyl)-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide) |
| CN112079795B (zh) * | 2020-09-16 | 2022-12-09 | 广东莱佛士制药技术有限公司 | 一种维奈托克中间体及其类似物的合成方法 |
| IT202100025976A1 (it) | 2021-10-06 | 2023-04-06 | Univ Degli Studi Di Perugia | Combinazione di principi attivi per il trattamento della leucemia acuta mieloide (LAM) con mutazione della nucleofosmina (NPM1) |
| CN114163369A (zh) * | 2021-12-17 | 2022-03-11 | 武汉工程大学 | 一种含硫/氧酯基芳烃化合物的制备方法 |
| CN116496239A (zh) * | 2022-12-14 | 2023-07-28 | 南京哈柏医药科技有限公司 | 一种维奈托克关键中间体及原料药的合成方法 |
| EP4421075A1 (en) | 2023-02-27 | 2024-08-28 | KRKA, d.d., Novo mesto | Process for the preparation of venetoclax and intermediates used therein |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB585940A (en) | 1944-09-01 | 1947-02-28 | Kodak Ltd | Bicyclic compounds containing the diphenylamine grouping, process of making them and their use in the colouration of textile materials other than cellulose |
| US3813443A (en) | 1970-11-18 | 1974-05-28 | Us Agriculture | Boll weevil sex attractant |
| SK288378B6 (sk) | 1999-02-10 | 2016-07-01 | Astrazeneca Ab | Použitie chinazolínových derivátov ako inhibítorov angiogenézy |
| RU2448099C2 (ru) | 2004-12-02 | 2012-04-20 | Дайити Санкё Компани, Лимитед | 7-членные циклические соединения, способы их получения и их фармацевтическое применение |
| CN1827582A (zh) * | 2006-04-18 | 2006-09-06 | 江苏中丹化工集团公司 | 6－[3－(1－金刚烷基)－4－甲氧基苯基]－2－萘甲酸甲酯的制备方法 |
| EP2452937A1 (en) * | 2007-04-30 | 2012-05-16 | Abbott Laboratories | Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
| JP2011515414A (ja) | 2008-03-20 | 2011-05-19 | アボット・ラボラトリーズ | Ｔｒｐｖ１アンタゴニストである中枢神経系薬剤を作製する方法 |
| US20100160322A1 (en) * | 2008-12-04 | 2010-06-24 | Abbott Laboratories | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| UA108193C2 (uk) * | 2008-12-04 | 2015-04-10 | Апоптозіндукуючий засіб для лікування раку і імунних і аутоімунних захворювань | |
| WO2010083441A2 (en) * | 2009-01-19 | 2010-07-22 | Abbott Laboratories | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| US8546399B2 (en) * | 2009-05-26 | 2013-10-01 | Abbvie Inc. | Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases |
| CN101990094B (zh) | 2009-08-05 | 2012-11-21 | 炬力集成电路设计有限公司 | 一种码流分析方法和装置 |
| CN102030651A (zh) * | 2009-09-28 | 2011-04-27 | 莱阳市盛华科技有限公司 | 2-氟-4-溴联苯基甲酸乙酯的合成方法 |
| TWI520960B (zh) * | 2010-05-26 | 2016-02-11 | 艾伯維有限公司 | 用於治療癌症及免疫及自體免疫疾病之細胞凋亡誘導劑 |
| DE102010027213A1 (de) * | 2010-07-15 | 2012-01-19 | Continental Automotive Gmbh | Verfahren und Steuergerät zum Steuern einer Brennkraftmaschine |
| UA113500C2 (xx) | 2010-10-29 | 2017-02-10 | Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб | |
| US20120277210A1 (en) | 2010-10-29 | 2012-11-01 | Abbott Laboratories | Solid dispersions containing an apoptosis-inducing agent |
| US20120129853A1 (en) | 2010-11-23 | 2012-05-24 | Abbott Laboratories | Methods of treatment using selective bcl-2 inhibitors |
| SI2643322T1 (en) | 2010-11-23 | 2018-01-31 | Abbvie Inc. | Salts and crystalline forms of an apoptosis induction agent |
-
2014
- 2014-03-12 BR BR112015021540-8A patent/BR112015021540B1/pt active IP Right Grant
- 2014-03-12 CN CN202010877947.6A patent/CN111960944A/zh active Pending
- 2014-03-12 WO PCT/US2014/024224 patent/WO2014165044A1/en active Application Filing
- 2014-03-12 SI SI201430826T patent/SI2970263T1/sl unknown
- 2014-03-12 PT PT14715501T patent/PT2970263T/pt unknown
- 2014-03-12 UY UY0001039847A patent/UY39847A/es not_active Application Discontinuation
- 2014-03-12 AU AU2014248742A patent/AU2014248742B2/en active Active
- 2014-03-12 EP EP22154798.7A patent/EP4019491A1/en active Pending
- 2014-03-12 LT LTEP14715501.4T patent/LT2970263T/lt unknown
- 2014-03-12 CN CN201711105971.2A patent/CN107721851B/zh active Active
- 2014-03-12 TW TW107109344A patent/TWI735759B/zh not_active IP Right Cessation
- 2014-03-12 CA CA2903797A patent/CA2903797C/en active Active
- 2014-03-12 UY UY0001035394A patent/UY35394A/es active IP Right Grant
- 2014-03-12 RS RS20180939A patent/RS57569B1/sr unknown
- 2014-03-12 EP EP17191299.1A patent/EP3293185A1/en not_active Withdrawn
- 2014-03-12 HU HUE14715501A patent/HUE039046T2/hu unknown
- 2014-03-12 JP JP2016501441A patent/JP6357220B2/ja active Active
- 2014-03-12 UY UY0001039848A patent/UY39848A/es not_active Application Discontinuation
- 2014-03-12 PE PE2019001821A patent/PE20191685A1/es unknown
- 2014-03-12 PE PE2015001892A patent/PE20151809A1/es unknown
- 2014-03-12 MX MX2018015299A patent/MX381065B/es unknown
- 2014-03-12 KR KR1020157029117A patent/KR102230339B1/ko active Active
- 2014-03-12 MY MYPI2019006129A patent/MY192466A/en unknown
- 2014-03-12 PL PL14715501T patent/PL2970263T3/pl unknown
- 2014-03-12 BR BR122021025053-7A patent/BR122021025053B1/pt active IP Right Grant
- 2014-03-12 CN CN201480025215.7A patent/CN105164128B/zh active Active
- 2014-03-12 SG SG10201701680YA patent/SG10201701680YA/en unknown
- 2014-03-12 MX MX2015012000A patent/MX365343B/es active IP Right Grant
- 2014-03-12 EP EP14715501.4A patent/EP2970263B1/en active Active
- 2014-03-12 CA CA3090936A patent/CA3090936C/en active Active
- 2014-03-12 RU RU2015143637A patent/RU2660424C2/ru active
- 2014-03-12 CA CA3183040A patent/CA3183040A1/en active Pending
- 2014-03-12 SG SG11201507360XA patent/SG11201507360XA/en unknown
- 2014-03-12 EP EP21194409.5A patent/EP3954687A1/en active Pending
- 2014-03-12 ES ES14715501.4T patent/ES2683378T3/es active Active
- 2014-03-12 EP EP19183264.1A patent/EP3569588A1/en not_active Withdrawn
- 2014-03-12 BR BR122021025062-6A patent/BR122021025062B1/pt active IP Right Grant
- 2014-03-12 DK DK14715501.4T patent/DK2970263T3/en active
- 2014-03-12 TW TW103108953A patent/TWI631121B/zh not_active IP Right Cessation
- 2014-12-03 UA UAA201509919A patent/UA118667C2/uk unknown
-
2015
- 2015-08-24 IL IL240779A patent/IL240779B/en active IP Right Grant
- 2015-09-04 PH PH12015501960A patent/PH12015501960B1/en unknown
- 2015-09-09 CL CL2015002548A patent/CL2015002548A1/es unknown
- 2015-09-16 CR CR20150495A patent/CR20150495A/es unknown
-
2016
- 2016-04-22 HK HK16104667.6A patent/HK1216644A1/zh unknown
- 2016-04-22 HK HK18110753.6A patent/HK1251231A1/zh unknown
-
2018
- 2018-01-23 IL IL257109A patent/IL257109B/en active IP Right Grant
- 2018-04-13 JP JP2018077547A patent/JP6578037B2/ja active Active
- 2018-05-21 PH PH12018501094A patent/PH12018501094A1/en unknown
- 2018-06-05 AU AU2018203977A patent/AU2018203977B2/en active Active
- 2018-08-09 HR HRP20181273TT patent/HRP20181273T1/hr unknown
- 2018-08-09 CY CY20181100834T patent/CY1120576T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20191685A1 (es) | Procesos para la preparacion de un agente inductor de la apoptosis | |
| PH12019501197A1 (en) | Therapeutically active compounds and their methods of use | |
| CU20160087A7 (es) | Indazolcarboxamidas, procedimientos para su preparación, preparaciones farmacéuticas que las contienen | |
| CL2015002164A1 (es) | Formulación combinada de dos compuesos antivirales. | |
| PH12015502649A1 (en) | Heterocyclic compounds as pest control agents | |
| PH12016500164B1 (en) | Therapeutically active compounds and their methods of use | |
| PH12015502839A1 (en) | Antiviral compounds | |
| CR20150078A (es) | Análogos de piridazina 1,4-disustituida y métodos para el tratamiento de condiciones relacionadas con la deficiencia de smn | |
| PE20151495A1 (es) | Compuestos de pirrolopirimidina como inhibidores de quinasas | |
| CR20150370A (es) | Compuestos antivirales | |
| NZ629996A (en) | 2’- substituted carba-nucleoside analogs for antiviral treatment | |
| EA201591537A1 (ru) | Производные бензотиофена и композиции, их содержащие, в качестве селективных супрессоров эстрогеновых рецепторов | |
| UY35146A (es) | Compuestos y composiciones para el tratamiento de enfermedades parasitarias | |
| EA201491362A1 (ru) | Анестезирующие соединения и способы их применения | |
| CR20150171A (es) | Benzamidas | |
| NI201600014A (es) | Compuestos y composiciones como inhibidores de la mek. | |
| EA201591628A1 (ru) | Дейтерированный палбоциклиб | |
| CO2017003004A2 (es) | Nuevas triazolo[4,5-d]pirimidinas | |
| EA201491525A1 (ru) | Спиро[2.4]гептаны для лечения инфекций, вызванных flaviviridae | |
| EA201792264A1 (ru) | Способы лечения воспалительных заболеваний | |
| MX2016004967A (es) | Tratamiento para cancer pancreatico. | |
| GT201600232A (es) | Derivados de diheterociclo enlazado a cicloalquilo | |
| MX362905B (es) | Tratamiento de combinacion. | |
| MX2014014814A (es) | Composicion farmaceutica para el tratamiento de inflamacion y dolor. | |
| MX368640B (es) | Composición farmacéutica para tratar inflamación y dolor. |